Dr Shelagh B. Coutts
Positions
Professor
Cumming School of Medicine, Department of Clinical Neurosciences
Professor
Cumming School of Medicine, Department of Radiology
Professor
Cumming School of Medicine, Department of Community Health Sciences
Full Member
Hotchkiss Brain Institute
Contact information
Phone number
Office: +1 (403) 944-1594
For media enquiries, contact
Kelly Johnston
Senior Communications Specialist
Please submit your media request here
Background
Credentials
FRCPC, Royal college of physicians and surgeons of Canada, 2006
MRCP (UK), Royal College of Physicians, 2000
Educational Background
MBChB Medicine, University of Edinburgh, 1997
BSc Pathology, University of Edinburgh, 1995
MD University of Edinburgh, 2005
Msc (with distinction) Clinical Trials , London School of Hygiene and Tropical Medicine, 2013
Biography
Dr. Coutts obtained her Undergraduate Medical Degree from the University of Edinburgh in 1997 and undertook general medical training at Glasgow Royal Infirmary prior to specializing in neurology. She moved to Calgary to complete a Fellowship in Stroke Neurology with Dr. Alastair Buchan and completed her Neurology Residency Training, receiving her FRCPC (Neurology) in 2006. During her stroke neurology training, she completed a postgraduate research degree on “Modern imaging: its role in prediction of outcome after stroke and TIA” and she received her MD (PhD equivalent) for this from the University of Edinburgh in 2005. She has a MSc in Clinical trials from the London School of Tropical Medicine and Hygiene in the United Kingdom. She is a full professor in the Departments of Clinical Neurosciences, Radiology, and Community Health Sciences at the University of Calgary, making her the first female full professor in acute stroke research in Canada. Dr. Coutts is the founder of CANWIN (Canadian Women in Stroke) and has been a strong advocate for increasing female representation in stroke research.
Her research interests include better diagnosis, triage and treatment of TIA and minor stroke patients. She is a clinical trialist that uses imaging to better identify patients that might benefit from treatment. She has been involved in the organisation of a number of international clinical trials in acute stroke and stroke prevention. She recently completed the TEMPO-2 study; this was a multi-centre, international randomized controlled trial assessing the use of TNK in minor stroke with intracranial occlusion that was published in the Lancet.
Dr. Coutts has received a number of awards for her work, including the “Siekert New Investigator Award” from the American Stroke Association, the "Michael J. Pessin award" in stroke leadership from the American Academy of Neurology and the Petro Canada Young Innovator Award in Community Health. She is the first recipient of the Heart and Stroke Foundation of Canada Distinguished Clinician Scientist award, supported in partnership with the CIHR Institute of Circulatory and Respiratory Health and AstraZeneca Canada Inc. She was also awarded a clinical investigator award from the Alberta Heritage Foundation for Medical Research. She was named in Avenue Magazine Calgary’s top 40 under 40 in 2012.
Awards
- Top 40 under 40, Avenue Magazine. 2012
- Michael J. Pessin award for Stroke Leadership , American Academy of Neurology. 2010
- CIHR-CMAJ: Top Achievements in Health Research Awards., CIHR-CMAJ. 2011
- Robert G. Siekert New Investigator award in Stroke , American Stroke Association . 2005
- Distinguished clinician Scientist, HSFC, CIHR Institute of Circulatory and Respiratory Health, and AstraZeneca Canada Inc.. 2009
- McDonald Scholarship, Heart and Stroke Foundation of Canada.. 2009
Are you the profile owner?
Login to edit.